114 studies found for:    RETINITIS PIGMENTOSA
Show Display Options
Rank Status Study
1 Recruiting Aflibercept for Macular Oedema With Underlying Retinitis Pigmentosa (AMOUR) Study
Conditions: Macular Oedema;   Retinitis Pigmentosa
Intervention: Drug: Aflibercept
2 Completed Autosomal Dominant Retinitis Pigmentosa: Prevalence of Known Genes Identification of New Loci / Genes
Condition: Autosomal Dominant Retinitis Pigmentosa
Intervention: Genetic: genetic analysis
3 Terminated A Study to Evaluate the Safety of CNTO 2476 in Patients With Advanced Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: CNTO 2476
4 Completed Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: intravitreal injection of autologous bone marrow stem cells
5 Not yet recruiting Clinical Trials of Continuous Oxygen Therapy Combined With Blue Light Deprivation in the Treatment of Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Continuous oxygen;   Device: blue light-absorbing sunglasses;   Drug: Compound thrombosis capsule sig: 1.5g/tid;   Drug: Ginkgo biloba pills sig: 300mg/tid;;   Drug: Vitamin B sig: 10mg/tid;   Drug: Vitamin AD sig: 1 tablet/tid
6 Completed Autologous Bone Marrow-Derived Stem Cells Transplantation For Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: intravitreal injection of autologous bone marrow stem cells
7 Recruiting Cone Rescue in Retinitis Pigmentosa by the Treatment of Lycium Barbarum
Condition: Retinitis Pigmentosa
Interventions: Dietary Supplement: Lycium Barbarum;   Dietary Supplement: Placebo
8 Recruiting Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: levodopa-carbidopa
9 Completed Stress and Vision Fluctuations in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention:
10 Completed Safety Study in Retinal Transplantation for Retinitis Pigmentosa.
Condition: Retinitis Pigmentosa.
Interventions: Device: Retinal transplantation instrument;   Device: Fetal tissue.
11 Completed
Has Results
Clinical Trial of Lutein for Patients With Retinitis Pigmentosa Receiving Vitamin A
Condition: Retinitis Pigmentosa
Interventions: Drug: Lutein;   Dietary Supplement: Cornstarch control
12 Completed A Study of Encapsulated Cell Technology (ECT) Implant for Patients With Late Stage Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: NT-501
13 Completed Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Procedure: Electro-acupuncture
14 Completed Trial of Oral Valproic Acid for Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Drug: Valproic Acid;   Drug: Placebo
15 Active, not recruiting Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Device: Electro-acupuncture;   Device: Laser Acupuncture;   Device: Transcorneal Electrical Stimulation;   Device: Sham Electro-acupuncture;   Device: Sham laser acupuncture;   Device: Sham transcorneal electrical stimulation
16 Recruiting Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Biological: BMMNCs
17 Completed Investigating the Effect of Vitamin A Supplementation on Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Intervention: Drug: Vitamin A
18 Recruiting Clinical Characterization on PDE6A-related Retinitis Pigmentosa in Preparation to a Gene Therapy Trial
Condition: Retinitis Pigmentosa
Intervention:
19 Recruiting Clinical Implication of Retinitis Pigmentosa Molecular Diagnostic Using High Throughput Sequencing.
Condition: Retinitis Pigmentosa
Intervention:
20 Active, not recruiting A Dose Ranging Study to Evaluate the Safety and Potential Efficacy of rhNGF in Patients With Retinitis Pigmentosa (RP)
Condition: Retinitis Pigmentosa
Interventions: Drug: rhNGF 60 µg/ml eye drops solution;   Drug: rhNGF 180 µg/ml eye drops solution;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years